Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
16th Mar 2015 7:00 am RNS BRILINTA PEGASUS-TIMI 54 STUDY
10th Mar 2015 6:24 pm RNS Filing of Form 20-F with SEC
10th Mar 2015 11:00 am RNS Annual Financial Report
6th Mar 2015 7:00 am RNS ASTRAZENECA REFINES ITS FINANCIAL REPORTING
4th Mar 2015 11:54 am RNS AZ TO PARTICIPATE IN US FDA EMDAC
3rd Mar 2015 7:05 am RNS Acquisition of Rights to Actavis' Portfolio
2nd Mar 2015 3:00 pm RNS Total Voting Rights
17th Feb 2015 7:00 am RNS Directorate Change
16th Feb 2015 7:00 am RNS PULMICORT RESPULES® US PATENT LITIGATION DECISION
5th Feb 2015 7:02 am RNS AZ to acquire Actavis' US respiratory portfolio
5th Feb 2015 7:00 am RNS Final Results
4th Feb 2015 9:00 am RNS Notice of Results
2nd Feb 2015 2:00 pm RNS Total Voting Rights
22nd Jan 2015 7:00 am RNS MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA
14th Jan 2015 7:43 am RNS BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT
2nd Jan 2015 2:00 pm RNS Total Voting Rights
19th Dec 2014 5:40 pm RNS LYNPARZA APPROVED BY THE US FDA
18th Dec 2014 7:00 am RNS LYNPARZAT APPROVED IN THE EUROPEAN UNION
9th Dec 2014 7:00 am RNS MOVENTIG approved in the EU for OIC
5th Dec 2014 5:03 pm RNS Jury verdict favours AZ in Nexium litigation
2nd Dec 2014 7:00 am RNS New Drug Application for IRESSA accepted by US FDA
1st Dec 2014 2:00 pm RNS Blocklisting Interim Review
1st Dec 2014 2:00 pm RNS Total Voting Rights
26th Nov 2014 7:00 am RNS POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY
24th Nov 2014 4:00 pm RNS Publication of Final Terms
24th Nov 2014 7:00 am RNS DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD
19th Nov 2014 5:00 pm RNS Launch and Pricing of a ?750m Bond
19th Nov 2014 9:41 am RNS Stabilisation Notice
18th Nov 2014 7:00 am RNS AZ strategy on track to deliver growth and value
17th Nov 2014 4:00 pm RNS Publication of Supplementary Prospectus
12th Nov 2014 7:00 am RNS AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS
10th Nov 2014 2:27 pm RNS Director/PDMR Shareholding
6th Nov 2014 7:04 am RNS ASTRAZENECA TO DIVEST MYALEPT TO AEGERION
6th Nov 2014 7:00 am RNS 3rd Quarter Results
6th Nov 2014 7:00 am RNS 3rd Quarter Results
5th Nov 2014 7:00 am RNS Notice of Results
4th Nov 2014 7:00 am RNS MEDIMMUNE ACQUIRES DEFINIENS
3rd Nov 2014 3:00 pm RNS Total Voting Rights
3rd Nov 2014 7:00 am RNS AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL
30th Oct 2014 7:00 am RNS US FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS
FTSE 100 Latest
Value8,837.91
Change26.87